OTC Markets EXMKT - Delayed Quote USD
U.S. Stem Cell, Inc. (USRM)
0.0002
0.0000
(0.00%)
At close: May 2 at 2:13:51 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-304.8520
-304.8520
-1,057.9390
-478.8860
Financing Cash Flow
270.5920
270.5920
1,078.7620
497.4560
End Cash Position
5.1330
5.1330
39.3930
18.5700
Interest Paid Supplemental Data
6.1130
6.1130
22.7620
40.9890
Issuance of Capital Stock
85
85
275
--
Issuance of Debt
27
27
766
195
Repayment of Debt
-27.6180
-27.6180
-52.2380
-45.7120
Free Cash Flow
-304.8520
-304.8520
-1,057.9390
-478.8860
12/31/2020 - 2/19/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OTLC Oncotelic Therapeutics, Inc.
0.0530
-0.93%
HALB Halberd Corporation
0.0021
0.00%
SYRE Spyre Therapeutics, Inc.
15.11
+3.07%
TSOI Therapeutic Solutions International, Inc.
0.0002
0.00%
RLFTF Relief Therapeutics Holding SA
2.7700
0.00%
INKT MiNK Therapeutics, Inc.
7.60
-4.76%
ACOG Alpha Cognition Inc. Common Stock
6.39
+6.86%
FHTX Foghorn Therapeutics Inc.
4.2400
+1.92%
VRPX Virpax Pharmaceuticals, Inc.
0.2750
+5.77%
ADXS Ayala Pharmaceuticals, Inc.
0.0342
-69.10%